An Open-label Study Investigating the Safety and Efficacy of rhPTH(1-84) in Subjects With Hypoparathyroidism
Phase of Trial: Phase III
Latest Information Update: 20 Dec 2018
At a glance
- Drugs Parathyroid hormone (Primary)
- Indications Hypoparathyroidism
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shire
- 11 Dec 2018 Status changed from not yet recruiting to recruiting.
- 03 Oct 2018 Planned End Date changed from 25 Mar 2020 to 5 Jun 2020.
- 03 Oct 2018 Planned primary completion date changed from 25 Mar 2020 to 5 Jun 2020.